MMM 3M Co

Dividend
2.06%
Previous close
$144.47
Est. 12 months change
+21.33%
Projected Price
$175.60

Profitability Metrics

Return on Equity (ROE)
74.81%
Return on Assets (ROA)
8.00%
Return on Invested Capital (ROIC)
22.05%
Weighted Average Cost of Capital (WACC)
9.70%
ROIC - WACC
12.34%
Updated : 2026-04-03 21:51 ET

Valuation Metrics

P/E Ratio
24.08
Forward P/E
16.71
PEG Ratio
2.13
Debt Current Ratio
1.71

Growth & Cash Flow

Gross Margin
39.91%
Operating Margin
19.04%
FCF Margin
5.60%
TTM Revenue Growth
2.05%
Projected 12M EPS Growth
44.09%

Price Change

Price % from 50 SMA
-7.61%
Price % from 200 SMA
-8.27%
6 Months
-9.02%
1 Year
-2.23%
2 Years
55.61%
Click here to see the list of ETFs containing MMM as a top holding :3M Co ETFs

Analysis

Company Overview

3M Company is a diversified industrial conglomerate manufacturing adhesives, safety equipment, healthcare products, and consumer goods sold across more than 200 countries. Sector: Industrials.

Overview

3M Co (MMM) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 22.05%, WACC is 9.70%, and the economic spread is 12.34%. On balance, ROIC clears WACC by a meaningful margin, suggesting the company is creating rather than consuming intrinsic value. Supporting metrics show ROE at 74.81% and ROA at 8.00%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

From a pricing standpoint, the company sits at trailing P/E of 24.08, forward P/E of 16.71, PEG of 2.13. The gap between trailing and forward multiples is meaningful but not wide — the market appears to be pricing a constructive but controlled earnings trajectory. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio of 1.71 suggests the the company have sufficient short-term liquidity without excess. In total, the multiple and liquidity readings describe a company where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 39.91%, operating margin at 19.04%, and free cash flow margin at 5.60%. Gross margins are moderate, reflecting industry conditions where input costs weigh more heavily on revenue. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, cash conversion is functional without being a standout feature of the company's quality profile. Read as a whole, the margin picture suggests a business with strengths in parts but no clear margin dominance end-to-end.

Growth & Forward Outlook

Revenue trends and analyst expectations together suggest: TTM revenue growth of 2.05% indicating muted but still positive top-line momentum across the company, while the estimated 12-month price change of 21.55%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 44.1%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. There is always distance between what is reported and what is priced; the question of whether that distance is closing or widening is what makes the setup interesting. In either direction, the fundamental driver of returns will be whether the company can sustain the trajectory that is already being priced. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Overall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.

This summary is based on publicly available quantitative data and is not intended as investment advice. Carefully consider your personal financial circumstances before making any decisions.